- Home
- Publications
- Publication Search
- Publication Details
Title
Cannabidiol as a Treatment for Mood Disorders: A Systematic Review
Authors
Keywords
-
Journal
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
Volume -, Issue -, Pages 070674371989519
Publisher
SAGE Publications
Online
2019-12-13
DOI
10.1177/0706743719895195
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association of Cannabis Use in Adolescence and Risk of Depression, Anxiety, and Suicidality in Young Adulthood
- (2019) Gabriella Gobbi et al. JAMA Psychiatry
- History of Benzodiazepine Prescriptions and Risk of Dementia: Possible Bias Due to Prevalent Users and Covariate Measurement Timing in a Nested Case-Control Study
- (2019) Kathryn Richardson et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Cannabidiol for the Reduction of Cue-Induced Craving and Anxiety in Drug-Abstinent Individuals With Heroin Use Disorder: A Double-Blind Randomized Placebo-Controlled Trial
- (2019) Yasmin L. Hurd et al. AMERICAN JOURNAL OF PSYCHIATRY
- Quality of life in adults enrolled in an open-label study of cannabidiol (CBD) for treatment-resistant epilepsy
- (2019) Tyler E. Gaston et al. EPILEPSY & BEHAVIOR
- The prevalence and clinical correlates of cannabis use and cannabis use disorder among patients with bipolar disorder: A systematic review with meta-analysis and meta-regression
- (2019) Jairo Vinícius Pinto et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Cannabidiol attenuates insular dysfunction during motivational salience processing in subjects at clinical high risk for psychosis
- (2019) Robin Wilson et al. Translational Psychiatry
- Complex polypharmacy in bipolar disorder: Side effect burden, adherence, and response predictors
- (2019) Vicki C. Fung et al. JOURNAL OF AFFECTIVE DISORDERS
- Comorbidity with more anxiety disorders associated with a poorer prognosis persisting at the 10-year follow-up among patients with major depressive disorder
- (2019) Ching-I Hung et al. JOURNAL OF AFFECTIVE DISORDERS
- Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial
- (2018) Philip McGuire et al. AMERICAN JOURNAL OF PSYCHIATRY
- Incidence, prevalence and clinical correlates of antidepressant-emergent mania in bipolar depression: a systematic review and meta-analysis
- (2018) Michele Fornaro et al. BIPOLAR DISORDERS
- Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder
- (2018) Lakshmi N Yatham et al. BIPOLAR DISORDERS
- Efficacy of artisanal preparations of cannabidiol for the treatment of epilepsy: Practical experiences in a tertiary medical center
- (2018) Giulia S. Porcari et al. EPILEPSY & BEHAVIOR
- A naturalistic examination of the perceived effects of cannabis on negative affect
- (2018) Carrie Cuttler et al. JOURNAL OF AFFECTIVE DISORDERS
- The burden of treatment-resistant depression: a systematic review of the economic and quality of life literature
- (2018) Karissa Johnston et al. JOURNAL OF AFFECTIVE DISORDERS
- Are cannabis-using and non-using patients different groups? Towards understanding the neurobiology of cannabis use in psychotic disorders
- (2018) Musa Basseer Sami et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Cannabidiol Induces Rapid and Sustained Antidepressant-Like Effects Through Increased BDNF Signaling and Synaptogenesis in the Prefrontal Cortex
- (2018) Amanda J. Sales et al. MOLECULAR NEUROBIOLOGY
- Sub-chronic treatment with cannabidiol but not with URB597 induced a mild antidepressant-like effect in diabetic rats
- (2018) Helen de Morais et al. NEUROSCIENCE LETTERS
- Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome
- (2018) Orrin Devinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antidepressant-like effect induced by Cannabidiol is dependent on brain serotonin levels
- (2018) Amanda J. Sales et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Developmental sensitivity to cannabis use patterns and risk for major depressive disorder in mid-life: findings from 40 years of follow-up
- (2018) Tabea Schoeler et al. PSYCHOLOGICAL MEDICINE
- Effect of Cannabidiol on Medial Temporal, Midbrain, and Striatal Dysfunction in People at Clinical High Risk of Psychosis
- (2018) Sagnik Bhattacharyya et al. JAMA Psychiatry
- Cannabidiol Administered During Peri-Adolescence Prevents Behavioral Abnormalities in an Animal Model of Schizophrenia
- (2018) Fernanda F. Peres et al. Frontiers in Pharmacology
- Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age
- (2018) José A. Crippa et al. Frontiers in Immunology
- Age-varying effects of cannabis use frequency and disorder on symptoms of psychosis, depression and anxiety in adolescents and adults
- (2018) Bonnie J. Leadbeater et al. ADDICTION
- Δ-9-Tetrahydrocannabinol and Cannabidiol produce dissociable effects on prefrontal cortical executive function and regulation of affective behaviors
- (2018) Hanna J. Szkudlarek et al. NEUROPSYCHOPHARMACOLOGY
- Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test
- (2018) Ila M. Linares et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- Examining the Association and Directionality between Mental Health Disorders and Substance Use among Adolescents and Young Adults in the U.S. and Canada—A Systematic Review and Meta-Analysis
- (2018) Sarvenaz Esmaeelzadeh et al. Journal of Clinical Medicine
- Effects of cannabidiol in males and females in two different rat models of depression
- (2018) Liat Shbiro et al. PHYSIOLOGY & BEHAVIOR
- Neuroprotection by cannabidiol and hypothermia in a piglet model of newborn hypoxic-ischemic brain damage
- (2018) Lorena Barata et al. NEUROPHARMACOLOGY
- Interactions between cannabidiol and commonly used antiepileptic drugs
- (2017) Tyler E. Gaston et al. EPILEPSIA
- The current status of artisanal cannabis for the treatment of epilepsy in the United States
- (2017) Dustin Sulak et al. EPILEPSY & BEHAVIOR
- Electroconvulsive therapy enhances endocannabinoids in the cerebrospinal fluid of patients with major depression: a preliminary prospective study
- (2017) Laura Kranaster et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Efficacy and safety of long-term antidepressant treatment for bipolar disorders – A meta-analysis of randomized controlled trials
- (2017) Bangshan Liu et al. JOURNAL OF AFFECTIVE DISORDERS
- Manual motor speed dysfunction as a neurocognitive endophenotype in euthymic bipolar disorder patients and their healthy relatives. Evidence from a 5-year follow-up study
- (2017) P. Correa-Ghisays et al. JOURNAL OF AFFECTIVE DISORDERS
- Complex psychotropic polypharmacy in bipolar disorder across varying mood polarities: A prospective cohort study of 2712 inpatients
- (2017) Julia C. Golden et al. JOURNAL OF AFFECTIVE DISORDERS
- Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2017) Theo Vos et al. LANCET
- Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group
- (2017) D P Hibar et al. MOLECULAR PSYCHIATRY
- Cannabis-associated psychosis: Neural substrate and clinical impact
- (2017) R.M. Murray et al. NEUROPHARMACOLOGY
- The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain
- (2017) Giulia Donvito et al. NEUROPSYCHOPHARMACOLOGY
- On the transdiagnostic nature of peripheral biomarkers in major psychiatric disorders: A systematic review
- (2017) Jairo Vinícius Pinto et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
- (2017) Orrin Devinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia
- (2017) Marco Aurélio Mori et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Cannabis Use and Hypomania in Young People: A Prospective Analysis
- (2017) Steven Marwaha et al. SCHIZOPHRENIA BULLETIN
- Endocannabinoid signalling modulates susceptibility to traumatic stress exposure
- (2017) Rebecca J. Bluett et al. Nature Communications
- Subcortical brain structure and suicidal behaviour in major depressive disorder: a meta-analysis from the ENIGMA-MDD working group
- (2017) M E Rentería et al. Translational Psychiatry
- Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life
- (2017) Antonio W. Zuardi et al. Frontiers in Pharmacology
- Areas of controversy in neuroprogression in bipolar disorder
- (2016) I. C. Passos et al. ACTA PSYCHIATRICA SCANDINAVICA
- Hippocampal neurochemical markers in bipolar disorder patients following the first-manic episode: A prospective 12-month proton magnetic resonance spectroscopy study
- (2016) Leonardo E Silveira et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex—Possible involvement of 5-HT1A and CB1 receptors
- (2016) A.G. Sartim et al. BEHAVIOURAL BRAIN RESEARCH
- Neuroprogression and episode recurrence in bipolar I disorder: A study of gray matter volume changes in first-episode mania and association with clinical outcome
- (2016) Jan-Marie Kozicky et al. BIPOLAR DISORDERS
- Volume, metabolites and neuroinflammation of the hippocampus in bipolar disorder – A combined magnetic resonance imaging and positron emission tomography study
- (2016) Bartholomeus C.M. (‘Benno’) Haarman et al. BRAIN BEHAVIOR AND IMMUNITY
- Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder
- (2016) Sidney H. Kennedy et al. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study
- (2016) Khalid A. Jadoon et al. DIABETES CARE
- Neurocognitive performance, subjective well-being, and psychosocial functioning after benzodiazepine withdrawal in patients with schizophrenia or bipolar disorder: a randomized clinical trial of add-on melatonin versus placebo
- (2016) Lone Baandrup et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Mortality trends in cardiovascular causes in schizophrenia, bipolar and unipolar mood disorder in Sweden 1987–2010
- (2016) Urban Ösby et al. EUROPEAN JOURNAL OF PUBLIC HEALTH
- Global burden of diseases, injuries, and risk factors for young people's health during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
- (2016) Ali H Mokdad et al. LANCET
- A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression
- (2016) D R Goldsmith et al. MOLECULAR PSYCHIATRY
- Subcortical volumetric abnormalities in bipolar disorder
- (2016) D P Hibar et al. MOLECULAR PSYCHIATRY
- Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: role of 5-HT1A receptors
- (2016) Raquel Linge et al. NEUROPHARMACOLOGY
- Prohedonic Effect of Cannabidiol in a Rat Model of Depression
- (2016) Gal Shoval et al. NEUROPSYCHOBIOLOGY
- Cannabidiol, neuroprotection and neuropsychiatric disorders
- (2016) Alline C. Campos et al. PHARMACOLOGICAL RESEARCH
- Prevalence of current anxiety disorders in people with bipolar disorder during euthymia: a meta-analysis
- (2016) B. Pavlova et al. PSYCHOLOGICAL MEDICINE
- Δ9-THC Intoxication by Cannabidiol-Enriched Cannabis Extract in Two Children with Refractory Epilepsy: Full Remission after Switching to Purified Cannabidiol
- (2016) José A. S. Crippa et al. Frontiers in Pharmacology
- Predictors of long-term work disability among patients with type I and II bipolar disorder: a prospective 18-month follow-up study
- (2015) Petri Arvilommi et al. BIPOLAR DISORDERS
- Cannabis use and mania symptoms: A systematic review and meta-analysis
- (2015) Melanie Gibbs et al. JOURNAL OF AFFECTIVE DISORDERS
- Endocannabinoid signalling in reward and addiction
- (2015) Loren H. Parsons et al. NATURE REVIEWS NEUROSCIENCE
- Anxious and non-anxious major depressive disorder in the World Health Organization World Mental Health Surveys
- (2015) R. C. Kessler et al. Epidemiology and Psychiatric Sciences
- Neuroinflammation in bipolar disorder – A [11C]-(R)-PK11195 positron emission tomography study
- (2014) Bartholomeus C.M. (Benno) Haarman et al. BRAIN BEHAVIOR AND IMMUNITY
- Impact of comorbid anxiety disorders and obsessive–compulsive disorder on 24-month clinical outcomes of bipolar I disorder
- (2014) Sung-Wan Kim et al. JOURNAL OF AFFECTIVE DISORDERS
- How Cannabis Causes Paranoia: Using the Intravenous Administration of ∆ 9 -Tetrahydrocannabinol (THC) to Identify Key Cognitive Mechanisms Leading to Paranoia
- (2014) Daniel Freeman et al. SCHIZOPHRENIA BULLETIN
- Nabiximols as an Agonist Replacement Therapy During Cannabis Withdrawal
- (2014) David J. Allsop et al. JAMA Psychiatry
- Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta-analysis
- (2013) C. Bourne et al. ACTA PSYCHIATRICA SCANDINAVICA
- Cannabidiol reduces cigarette consumption in tobacco smokers: Preliminary findings
- (2013) Celia J.A. Morgan et al. ADDICTIVE BEHAVIORS
- Metabolic Syndrome and Metabolic Abnormalities in Bipolar Disorder: A Meta-Analysis of Prevalence Rates and Moderators
- (2013) Davy Vancampfort et al. AMERICAN JOURNAL OF PSYCHIATRY
- Comparative psychometric analyses of the SCL-90-R and its short versions in patients with affective disorders
- (2013) Ulrich Prinz et al. BMC Psychiatry
- The endocannabinoid system and emotional processing: A pharmacological fMRI study with ∆9-tetrahydrocannabinol
- (2013) Matthijs G. Bossong et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Cannabinoid Receptor Genotype Moderation of the Effects of Childhood Physical Abuse on Anhedonia and Depression
- (2012) Arpana Agrawal et al. ARCHIVES OF GENERAL PSYCHIATRY
- Acute Effects of a Single, Oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) Administration in Healthy Volunteers
- (2012) R. Martin-Santos et al. CURRENT PHARMACEUTICAL DESIGN
- Longitudinal associations of cannabis and illicit drug use with depression, suicidal ideation and suicidal attempts among Nova Scotia high school students
- (2012) Daniel Rasic et al. DRUG AND ALCOHOL DEPENDENCE
- Cannabidiol for the treatment ofcannabiswithdrawal syndrome: a case report
- (2012) J. A. S. Crippa et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Activation of Cannabinoid Receptor 2 Attenuates Leukocyte-Endothelial Cell Interactions and Blood-Brain Barrier Dysfunction under Inflammatory Conditions
- (2012) S. H. Ramirez et al. JOURNAL OF NEUROSCIENCE
- Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial
- (2012) Russell K. Portenoy et al. JOURNAL OF PAIN
- Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
- (2012) F M Leweke et al. Translational Psychiatry
- Administration of cannabidiol and imipramine induces antidepressant-like effects in the forced swimming test and increases brain-derived neurotrophic factor levels in the rat amygdala.
- (2011) Gislaine Z. Réus et al. ACTA NEUROPSYCHIATRICA
- Prevalence and Correlates of Bipolar Spectrum Disorder in the World Mental Health Survey Initiative
- (2011) Kathleen R. Merikangas et al. ARCHIVES OF GENERAL PSYCHIATRY
- Cross-national epidemiology of DSM-IV major depressive episode
- (2011) Evelyn Bromet et al. BMC Medicine
- The Cannabis Withdrawal Scale development: Patterns and predictors of cannabis withdrawal and distress
- (2011) David J. Allsop et al. DRUG AND ALCOHOL DEPENDENCE
- Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients
- (2011) Mateus M Bergamaschi et al. NEUROPSYCHOPHARMACOLOGY
- Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being
- (2011) C. J. A. Morgan et al. PSYCHOLOGICAL MEDICINE
- Cannabis with high cannabidiol content is associated with fewer psychotic experiences
- (2011) Christian D. Schubart et al. SCHIZOPHRENIA RESEARCH
- Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
- (2010) José Alexandre S Crippa et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Antidepressant-like effect of Δ9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L.
- (2010) Abir T. El-Alfy et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Stuck in a rut: rethinking depression and its treatment
- (2010) Paul E. Holtzheimer et al. TRENDS IN NEUROSCIENCES
- Distinct Effects of Δ9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing
- (2009) Paolo Fusar-Poli et al. ARCHIVES OF GENERAL PSYCHIATRY
- Brain Cannabinoid CB2 Receptor in Schizophrenia
- (2009) Hiroki Ishiguro et al. BIOLOGICAL PSYCHIATRY
- Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors
- (2009) TV Zanelati et al. BRITISH JOURNAL OF PHARMACOLOGY
- Weight gain, obesity, and metabolic indices following a first manic episode: Prospective 12-month data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM)
- (2009) David J. Bond et al. JOURNAL OF AFFECTIVE DISORDERS
- Effects of cannabidiol on amphetamine-induced oxidative stress generation in an animal model of mania
- (2009) Samira S Valvassori et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- Reduced Cortical Cannabinoid 1 Receptor Messenger RNA and Protein Expression in Schizophrenia
- (2008) Stephen M. Eggan et al. ARCHIVES OF GENERAL PSYCHIATRY
- Cannabidiol was ineffective for manic episode of bipolar affective disorder
- (2008) AW Zuardi et al. JOURNAL OF PSYCHOPHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started